Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
27.39
-0.38 (-1.37%)
At close: Mar 16, 2026, 4:00 PM EDT
26.86
-0.53 (-1.94%)
After-hours: Mar 16, 2026, 7:17 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.64 billion as of March 16, 2026. Its market cap has increased by 66.37% in one year.
Market Cap
1.64B
Enterprise Value
1.18B
1-Year Change
66.37%
Ranking
Category
Stock Price
$27.39
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.64B, an increase of 68.16%. That is a compound annual growth rate of 18.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.66B | 81.70% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.72B |
| Zymeworks | 1.69B |
| Sionna Therapeutics | 1.68B |
| Novavax | 1.67B |
| Generate Biomedicines | 1.67B |
| Vericel | 1.65B |
| Innoviva | 1.63B |
| Agios Pharmaceuticals | 1.63B |